Baird cuts Axsome Therapeutics target price to $220 from $246
AXSM•Baird cut its target price for Axsome Therapeutics to $220 from $246.
Related News
Cohen & Steers price objective cut to $46 from $53
CNS•
Emerson: Morgan Stanley cuts target price to $140 from $145
EMR•
Nvidia orders data centre clients to reduce China exposure
NVDA•
JPMorgan cuts Ryan Specialty Holdings target price to $44 from $45
RYAN•
SS&C flags operational challenges as retail access to private markets expands
SSNC•